Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC – SHANGHAI, China and REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) today announced […]

Read More

Xometry to Announce Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023

ROCKVILLE, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global online marketplace connecting enterprise buyers with suppliers of manufacturing services, today announced it will report its fourth quarter and full-year 2022 financial results before the market open on March 1, 2023. Xometry will host its conference call and webcast to discuss […]

Read More

GreySkies Service Assurance Software Platform Helps Orange Egypt Reduce Operational Costs

GreySkies provides end-to-end visibility for Orange Egypt’s fixed and mobile networks Featured Image for Greyskies Inc. SEATTLE, Feb. 15, 2023 (GLOBE NEWSWIRE) — Today GreySkies, a telecommunications service assurance software provider, announced the completion of the deployment of its market-leading platform at Orange Egypt, the world’s leading telecommunications operator, enabling the reduction of their service […]

Read More
Back To Top